Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shogo Ohkoshi

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Internal Medicine (Tokyo, Japan)|April 6, 2007
Decompensated lamivudine-resistant hepatitis B virus-related cirrhosis treated successfully with adefovir dipivoxil allowing surgery for hepatocellular carcinomaMasaaki Takamura, Takafumi Ichida, Shogo Ohkoshi, et al.
Cancer Letters|January 24, 2012
Blockade of ataxia telangiectasia mutated sensitizes hepatoma cell lines to sorafenib by interfering with Akt signalingShun Fujimaki, Yasunobu Matsuda, Toshifumi Wakai, et al.
World Journal of Hepatology|March 7, 2017
Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis CSatoshi Yamagiwa, Toru Ishikawa, Nobuo Waguri, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 2, 2007
Early upsurge in anti-HBs titer possibly caused by the immunomodulative, not by the mutagenetic effect of interferon and ribavirinKazuhide Yamazaki, Shogo Ohkoshi, Masaki Maruyama, et al.
Pathology International|April 20, 2010
Rectal administration of tranilast ameliorated acute colitis in mice through increased expression of heme oxygenase-1Xiaomei Sun, Kenji Suzuki, Masaki Nagata, et al.
Journal of Hepatology|July 16, 2011
Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrenceHiroteru Kamimura, Satoshi Yamagiwa, Atsunori Tsuchiya, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|February 11, 2011
[A case with chronic hepatitis C who developed liver cirrhosis due to liver dysfunction caused by pegylated interferon plus ribavirin treatment despite negativity of serum HCV RNA, during therapy]Shogo Ohkoshi, Shin-Ichi Morita, Yukari Tanaka, et al.
Hepato-Gastroenterology|March 2, 2006
Common clinicopathological features of the patients with chronic hepatitis B virus infection who developed hepatocellular carcinoma after seroconversion to anti-HBs--a consideration of the pathogenesis of HBV-induced hepatocellular carcinoma and a strategy to inhibit itYasunori Tsuboi, Shogo Ohkoshi, Masahiko Yano, et al.
Digestive Diseases and Sciences|November 20, 2008
Progression of hypermethylation of the p16(INK4A) gene from normal liver to nontumorous liver and hepatocellular carcinoma: an evaluation using quantitative PCR analysisSo Kurita, Shogo Ohkoshi, Masahiko Yano, et al.
Journal of Hepatology|December 18, 2007
Temporal treatment with interferon-beta prevents hepatocellular carcinoma in hepatitis B virus X gene transgenic miceKazuhide Yamazaki, Kenta Suzuki, Shogo Ohkoshi, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Internal Medicine (Tokyo, Japan)|April 6, 2007
Decompensated lamivudine-resistant hepatitis B virus-related cirrhosis treated successfully with adefovir dipivoxil allowing surgery for hepatocellular carcinomaMasaaki Takamura, Takafumi Ichida, Shogo Ohkoshi, et al.
Cancer Letters|January 24, 2012
Blockade of ataxia telangiectasia mutated sensitizes hepatoma cell lines to sorafenib by interfering with Akt signalingShun Fujimaki, Yasunobu Matsuda, Toshifumi Wakai, et al.
World Journal of Hepatology|March 7, 2017
Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis CSatoshi Yamagiwa, Toru Ishikawa, Nobuo Waguri, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 2, 2007
Early upsurge in anti-HBs titer possibly caused by the immunomodulative, not by the mutagenetic effect of interferon and ribavirinKazuhide Yamazaki, Shogo Ohkoshi, Masaki Maruyama, et al.
Pathology International|April 20, 2010
Rectal administration of tranilast ameliorated acute colitis in mice through increased expression of heme oxygenase-1Xiaomei Sun, Kenji Suzuki, Masaki Nagata, et al.
Journal of Hepatology|July 16, 2011
Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrenceHiroteru Kamimura, Satoshi Yamagiwa, Atsunori Tsuchiya, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|February 11, 2011
[A case with chronic hepatitis C who developed liver cirrhosis due to liver dysfunction caused by pegylated interferon plus ribavirin treatment despite negativity of serum HCV RNA, during therapy]Shogo Ohkoshi, Shin-Ichi Morita, Yukari Tanaka, et al.
Hepato-Gastroenterology|March 2, 2006
Common clinicopathological features of the patients with chronic hepatitis B virus infection who developed hepatocellular carcinoma after seroconversion to anti-HBs--a consideration of the pathogenesis of HBV-induced hepatocellular carcinoma and a strategy to inhibit itYasunori Tsuboi, Shogo Ohkoshi, Masahiko Yano, et al.
Digestive Diseases and Sciences|November 20, 2008
Progression of hypermethylation of the p16(INK4A) gene from normal liver to nontumorous liver and hepatocellular carcinoma: an evaluation using quantitative PCR analysisSo Kurita, Shogo Ohkoshi, Masahiko Yano, et al.
Journal of Hepatology|December 18, 2007
Temporal treatment with interferon-beta prevents hepatocellular carcinoma in hepatitis B virus X gene transgenic miceKazuhide Yamazaki, Kenta Suzuki, Shogo Ohkoshi, et al.
Pageof 5